Pharmaceutical company Mallinckrodt’s stocks plunged to a record low after it was reported that the troubled opioid maker had hired bankruptcy advisors. The stock tumbled 39% and closed at $1.59. Mallinckrodt’s shares were at a peak in 2015 at $132.51 a share. Since then, they have lost a staggering 95% of their value. Mallinckrodt chief […]
